http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0595526-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6831b19bfc354357342f7c7da79fc162 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
filingDate | 1993-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1997-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f66336db5e9cd964d574fbc6878563cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92364eafc6ba785c084eba1f4a69c1db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa925a0c13874254b80b5f18a98bc55c |
publicationDate | 1997-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0595526-B1 |
titleOfInvention | Peripheral circulation improving agent |
abstract | There is disclosed a (-)-cis-1,5-benzothiazepine derivative represented by the following formula or a pharmaceutically acceptable salt thereof: <CHEM> wherein R<1> represents a lower alkyl group or a lower alkoxy group; R<2> represents hydrogen atom or a lower alkanoyl group; R<3> represents a lower alkyl group; R<4> represents hydrogen atom or a lower alkyl group; R<5> represent hydrogen atom, a lower alkyl group or a hydroxy lower alkyl group; and A represents a lower alkylene group, which is a prophylactic and/or curing agent of chronic arterial obstruction, Raynoud's disease, Bu14erger's disease, and the like. |
priorityDate | 1992-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 71.